Further interrogation of KRAS-mutated CRC revealed no significant difference in female representation (OR = 0.985, p = 0.955) or survival (p = 0.7774) between the proximal and distal tumor locations (Figure S6). This evidence concerns the gene KRAS and colorectal carcinoma.